Semin Cancer Biol 2004, 14: 123–30.CrossRefPubMed 10. Iwata T, Miyata Y, Kanda S, Nishikido M, Hayashi T, Sakai H, Kanetake H: Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Urology 2008, 71: 749–54.CrossRefPubMed 11. Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature 2005, 438: 946–53.CrossRefPubMed 12. Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, Saleem MA, Mathieson PW, Bates
DO, Harper SJ: VEGF-C promotes survival in podocytes. Am J Physiol Renal Physiol 2006, 291: F196–207.CrossRefPubMed 13. Aydin S, Signorelli S, Lechleitner T, Joannidis M, Pleban C, Perco P, Pfaller W, Jennings P: Influence of microvascular Captisol nmr selleck endothelial cells on transcriptional
regulation of proximal tubular epithelial cells. Am J Physiol Cell Physiol 2008, 294: C543–54.CrossRefPubMed 14. Tufro A, Norwood VF, Carey RM, Gomez RA: Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol 1999, 10: 2125–34.PubMed 15. Djordjevic G, Mozetic V, Mozetic DV, Licul V, Ilijas KM, Mustac E, Oguic R, Fuckar Z, Jonjic N: Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell RG7420 manufacturer carcinoma. Pathol Res Pract 2007, 203: 99–106.CrossRefPubMed 16. Fuhrman Tau-protein kinase SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6: 655–63.CrossRefPubMed 17. Fergelot P, Rioux-Leclercq N, Patard JJ: Molecular pathways of tumour angiogenesis and new targeted therapeutic approaches in renal cancer. Prog Urol 2005, 15: 1021–9.PubMed 18. Nowicki M, Ostalska-Nowicka D, Kaczmarek M, Miskowiak B, Witt M: The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms’
tumour). Histopathology 2007, 50: 358–64.CrossRefPubMed 19. Paradis V, Lagha NB, Zeimoura L, Blanchet P, Eschwege P, Ba N, Benoît G, Jardin A, Bedossa P: Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000, 436: 351–6.CrossRefPubMed 20. Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY: Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int 2004, 93: 1087–93.CrossRefPubMed 21. Jacobsen J, Grankvist K, Rasmuson T, Bergh A, Landberg G, Ljungberg B: Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int 2004, 93: 297–302.CrossRefPubMed 22. Leppert JT, Lam JS, Yu H, Seligson DB, Dong J, Horvath S: Targeting the vascular endothelial growth factor pathway in renal cell carcinoma: a tissue array based analysis.